BriaCell Therapeutics Corp.
BCTXLNasdaq
$0.92
↑ +2.2%Jul 17 close · end-of-day
Price
1Y↓ -1.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$6.7M
Enterprise Value
-$16.1M
P/E
0.4
P/S
—
P/B
0.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$30.7M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-131.0%
ROIC
-4185.6%
Debt / Equity
—
Net Cash
$22.8M
Return 1Y
—
Earnings
BCTXL Q3 2026 Earnings
Period ends 2026-04-30
MetricActualYoY
Revenue——
Diluted EPS-$0.99↓ -94.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — |
| Operating income | — | -$7.0M | — | -$15.3M | -$23.3M | -$33.3M | -$27.2M |
| Net income | — | -$13.8M | — | -$26.8M | -$20.3M | -$4.8M | -$26.3M |
| Diluted EPS | — | — | — | -$1.73 | -$1.30 | -$43.68 | -$62.19 |
| Operating cash flow | — | -$7.8M | — | -$12.5M | -$23.7M | -$24.1M | -$28.2M |
| Free cash flow | — | — | — | — | — | -$24.6M | — |
| Gross margin | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — |
| Line item | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$5.8M | -$5.2M | -$7.2M | -$6.3M | -$8.6M | -$8.3M | -$7.5M | -$7.6M |
| Net income | -$1.2M | -$5.8M | -$6.3M | -$6.1M | -$8.1M | -$8.2M | -$7.2M | -$7.2M |
| Diluted EPS | -$34.15 | -$32.67 | -$23.31 | -$16.42 | $10.21 | -$4.35 | -$2.58 | -$0.99 |
| Operating cash flow | -$4.0M | -$7.0M | -$5.9M | -$7.2M | -$8.1M | -$7.7M | -$8.0M | -$7.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Coming soonHeadlines for BCTXL will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.